Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on Sales

Medicure (MCUJF) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Medicure (MCUJF) over the last 17 years, with Q3 2025 value amounting to 10.9%.

  • Medicure's EBIT Margin rose 333500.0% to 10.9% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.06%, marking a year-over-year increase of 2700.0%. This contributed to the annual value of 23.94% for FY2024, which is 104100.0% down from last year.
  • According to the latest figures from Q3 2025, Medicure's EBIT Margin is 10.9%, which was up 333500.0% from 10.48% recorded in Q2 2025.
  • Medicure's 5-year EBIT Margin high stood at 98.27% for Q4 2023, and its period low was 22.45% during Q3 2024.
  • Its 5-year average for EBIT Margin is 20.42%, with a median of 3.64% in 2023.
  • As far as peak fluctuations go, Medicure's EBIT Margin skyrocketed by 1697100bps in 2021, and later tumbled by -922300bps in 2024.
  • Medicure's EBIT Margin (Quarter) stood at 40.23% in 2021, then skyrocketed by 113bps to 85.73% in 2022, then grew by 15bps to 98.27% in 2023, then decreased by -11bps to 87.85% in 2024, then crashed by -88bps to 10.9% in 2025.
  • Its EBIT Margin was 10.9% in Q3 2025, compared to 10.48% in Q2 2025 and 11.94% in Q1 2025.